Ionis Pharma’s genetic disease drug succeeds in late-stage study – Times of India
Ionis Pharmaceuticals said on Monday its experimental drug reduced the occurrence of painful attacks in patients with a rare genetic disease that triggers frequent episodes of swelling. The life-threatening genetic disease called hereditary angioedema causes unpredictable and frequent severe swelling of the skin, gastrointestinal tract, upper respiratory system, face and throat. Shares of the drugmaker…
